Tongjitang Chinese Medicines Company Reports Q4 EPS of $0.08

Tongjitang Chinese Medicines Company TCM today announced its financial results for the quarter ended December 31, 2010. Net revenue from continuing operations(i) increased 33.6% to RMB 188.8 million ($28.6 million)(ii), from RMB 141.3 million in the prior year period. Total net income attributable to the Company was RMB 13.0 million ($2.0 million), which yielded earnings per ADS of RMB 0.50 ($0.08) and earnings per share of RMB 0.13 ($0.02). Non-GAAP adjusted EBITDA per share was RMB 0.25 ($0.04), compared to RMB 0.14 in the fourth quarter of 2009.